Figures below are as of 21 Jul 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹0 |
| Estimated listing gain | +0.0% |
| Estimated listing price | ₹79 |
| Issue price | ₹79 |
| Issue size | ₹165.00 Cr |
| Subscription | 7.27x |
| Open date | 20 Feb 2026 |
| Close date | 24 Feb 2026 |
| Listing date | 27 Feb 2026 |
| Listing at | BSE, NSE |
| IPO type | Mainboard IPO |
| Registrar | Bigshare Services Pvt.Ltd. |
As of 21 Jul 2026, the grey market premium (GMP) for the Gaudium IVF & Women Health Ltd. IPO is ₹0, implying an estimated listing gain of about +0.0% and an estimated listing price near ₹79. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Gaudium IVF & Women Health Ltd. IPO is open for subscription from 20 Feb 2026 to 24 Feb 2026. It is expected to list on 27 Feb 2026.
The Gaudium IVF & Women Health Ltd. IPO is priced at ₹79 per share, with a total issue size of ₹165.00 Cr.
As of 21 Jul 2026, the Gaudium IVF & Women Health Ltd. IPO is subscribed 7.27x.